Drug manufacture can benefit from flow synthesis, in which raw materials are fed into a sequence of reactors, producing the drug as a continuous output. A flow strategy that capitalizes on solid catalysts has now been realized. See Letter p.329
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Tsubogo, T., Oyamada, H. & Kobayashi, S. Nature 520, 329–332 (2015).
Pastre, J. C., Browne, D. L. & Ley, S. V. Chem. Soc. Rev. 42, 8849–8869 (2013).
Baxendale, I. R. et al. J. Pharm. Sci. 104, 781–791 (2015).
Hopkin, M. D., Baxendale, I. R. & Ley, S. V. Chem. Commun. 46, 2450–2452 (2010).
Snead, D. R. & Jamison, T. F. Angew. Chem. Int. Edn 54, 983–987 (2015).
Battilocchio, C., Hawkins, J. M. & Ley, S. V. Org. Lett. 15, 2278–2281 (2013).
Chorghade, R., Battilocchio, C., Hawkins, J. M. & Ley, S. V. Org. Lett. 15, 5698–5701 (2013).
Battilocchio, C., Hawkins, J. M. & Ley, S. V. Org. Lett. 16, 1060–1063 (2014).
Ouchi, T., Battilocchio, C., Hawkins, J. M. & Ley, S. V. Org. Process Res. Dev. 18, 1560–1566 (2014).
Markarian, J. Pharm. Technol. 38(11), 52–54 (2014).
Truppo, M. D., Janey, J. M. & Hughes, G. US patent application US20140106413 A1 (2014).
Rights and permissions
About this article
Cite this article
Hawkins, J. Streamlining drug synthesis. Nature 520, 302–303 (2015). https://doi.org/10.1038/520302a